Yonal, I. Et Al. 2012. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.34, no.3 , 388-396.

Yonal, I., Pinarbasi, B., Hindilerden, F., Hancer, V. S., Nalcaci, M., Kaymakoglu, S., ... Diz-Kucukkaya, R.(2012). The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.34, no.3, 388-396.

Yonal, İpek Et Al. "The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis," JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.34, no.3, 388-396, 2012

Yonal, İpek Y. Et Al. "The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis." JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.34, no.3, pp.388-396, 2012

Yonal, I. Et Al. (2012) . "The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis." JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.34, no.3, pp.388-396.

@article{article, author={İpek YÖNAL HİNDİLERDEN Et Al. }, title={The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis}, journal={JOURNAL OF THROMBOSIS AND THROMBOLYSIS}, year=2012, pages={388-396} }